They are using a multi drug combination of Venetoclax which was developed in the 1980s and Retuximab or Ibrutinib which is doubling the survival rates of patients with Lymphocytic leukaemia and mantle cell Lymphoma.No chemo and no side effects.Its not a cure but is halving the death rate of these cancers.
They are using a multi drug combination of Venetoclax which was...
Add to My Watchlist
What is My Watchlist?
